Literature DB >> 14530162

Modulation of repopulation processes in oral mucosa: experimental results.

W Dörr1.   

Abstract

PURPOSE: Repopulation processes, i.e. the tissue regeneration responses to radiotherapy with increasing overall treatment time, are the predominant factors defining the radiation tolerance of turnover tissues, such as squamous epithelia of the skin or gastrointestinal tract. The purpose was to assess experimental approaches for the modulation, i.e. stimulation of repopulation, in normal oral mucosa.
MATERIALS AND METHODS: Numerous studies have been performed to identify and quantify the efficacy of repopulation processes in oral mucosa in experimental animal models, mainly mouse lip and tongue mucosa, and in some clinical studies. However, only a few investigations focused on the stimulation of these processes, aiming at a reduction in oral mucosal side-effects of radiotherapy. The present review summarizes the biological mechanisms underlying effective repopulation, and delineates experimental approaches for effective stimulation of these processes, eventually resulting in an increase in oral mucosal radiation tolerance.
RESULTS: Repopulation in oral mucosa is a complex process dominated by a substantial reorganization of the proliferative structure, including a loss of the stem cell division asymmetry and acceleration of stem cell proliferation, as well as abortive divisions of 'sterilized' cells. Repopulation in mouse oral mucosa is more effective if the initial dose intensity (weekly dose) during the first treatment week(s) is increased. Stem cell production occurs mainly during the treatment weeks, while during treatment breaks, including weekends, differentiating (transit) cells are preferentially produced. Stimulation of superficial cell loss, e.g. by topical administration of mild astringent agents, stimulates mucosal proliferation. This translates into increased radiation tolerance to fractionated irradiation in experimental systems, like mouse tongue mucosa. In clinical studies, a reduction of oral mucosal reactions using the same approach was found during an accelerated radiotherapy regimen, but not during conventionally fractionated protocols. Keratinocyte growth factor has been demonstrated to reduce oral mucosal reactions significantly to single dose and fractionated irradiation. This effect is presumably based on an interaction with repopulation processes.
CONCLUSIONS: Repopulation in oral mucosa is a highly complex process, which includes a substantial reorganization of the proliferative structure. In experimental models, its efficacy can be modulated by changes in the fractionation protocol, but more effectively by intervention in the regulation processes, e.g. by stimulation of proliferation through enhancement of cell loss. An alternative promising approach is the administration of growth factors, like keratinocyte growth factor, for effective modulation of oral mucosal repopulation. However, selectivity for the normal tissue, as well as biological mechanisms, must be studied in detail in relevant animal models.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530162     DOI: 10.1080/09553002310001600925

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  15 in total

1.  Effects of bone marrow or mesenchymal stem cell transplantation on oral mucositis (mouse) induced by fractionated irradiation.

Authors:  M Schmidt; J Haagen; R Noack; A Siegemund; P Gabriel; W Dörr
Journal:  Strahlenther Onkol       Date:  2014-01-24       Impact factor: 3.621

2.  Tumour repopulation and the role of abortive division in squamous cell carcinomas during chemotherapy.

Authors:  L G Marcu
Journal:  Cell Prolif       Date:  2014-05-13       Impact factor: 6.831

3.  Application of organ tolerance dose-constraints in clinical studies in radiation oncology.

Authors:  Wolfgang Dörr; Thomas Herrmann; Michael Baumann
Journal:  Strahlenther Onkol       Date:  2014-03-07       Impact factor: 3.621

4.  Mechanisms of taste bud cell loss after head and neck irradiation.

Authors:  Ha M Nguyen; Mary E Reyland; Linda A Barlow
Journal:  J Neurosci       Date:  2012-03-07       Impact factor: 6.167

5.  Modulation of radiation-induced oral mucositis by pentoxifylline: preclinical studies.

Authors:  Sylvia Gruber; Margret Schmidt; Eva Bozsaky; Kathrin Wolfram; Julia Haagen; Bettina Habelt; Martin Puttrich; Wolfgang Dörr
Journal:  Strahlenther Onkol       Date:  2014-10-29       Impact factor: 3.621

6.  Effect of post-exposure administration of keratinocyte growth factor (Palifermin) on radiation effects in oral mucosa in mice.

Authors:  Yasemin Kiliç; Katja Rajewski; Wolfgang Dörr
Journal:  Radiat Environ Biophys       Date:  2006-11-14       Impact factor: 1.925

7.  Effect of tumour-cell-derived or recombinant keratinocyte growth factor (KGF) on proliferation and radioresponse of human epithelial tumour cells (HNSCC) and normal keratinocytes in vitro.

Authors:  Andrea Hille; Susanne Grüger; Hans Christiansen; Hendrik A Wolff; Beate Volkmer; Jörg Lehmann; Wolfgang Dörr; Margret Rave-Fränk
Journal:  Radiat Environ Biophys       Date:  2010-03-07       Impact factor: 1.925

Review 8.  Pathophysiology of Radiation-Induced Dysphagia in Head and Neck Cancer.

Authors:  Suzanne N King; Neal E Dunlap; Paul A Tennant; Teresa Pitts
Journal:  Dysphagia       Date:  2016-04-20       Impact factor: 3.438

Review 9.  Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity?

Authors:  Carsten Herskind; Christopher J Talbot; Sarah L Kerns; Marlon R Veldwijk; Barry S Rosenstein; Catharine M L West
Journal:  Cancer Lett       Date:  2016-03-02       Impact factor: 8.679

10.  Modulation of radiation-induced oral mucositis by thalidomide : Preclinical studies.

Authors:  Katharina Frings; Sylvia Gruber; Peter Kuess; Miriam Kleiter; Wolfgang Dörr
Journal:  Strahlenther Onkol       Date:  2016-06-09       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.